TABLE OF CONTENTS
1 INTRODUCTION 23
1.1 OBJECTIVES OF THE STUDY 23
1.2 MARKET DEFINITION 23
1.3 OVERVIEW OF GLOBAL DIGITAL HEALTH MONITORING DEVICES MARKET 24
1.4 CURRENCY AND PRICING 25
1.5 LIMITATION 25
1.6 MARKETS COVERED 25
2 MARKET SEGMENTATION 28
2.1 MARKETS COVERED 28
2.2 GEOGRAPHIC SCOPE 29
2.3 YEARS CONSIDERED FOR THE STUDY 30
2.4 CURRENCY AND PRICING 30
2.5 RESEARCH METHODOLOGY 31
2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 34
2.7 SECONDARY SOURCES 35
2.8 ASSUMPTIONS 35
2.9 DBMR MARKET CHALLENGE MATRIX 36
2.10 DBMR VENDOR SHARE ANALYSIS 37
3 MARKET OVERVIEW 38
3.1 DRIVERS 40
3.1.1 RISING AWARENESS CONCERNING HEALTH AMONG PEOPLE AND GROWING NEED FOR REMOTE PATIENT MONITORING SERVICES 40
3.1.2 INCREASING PREVALENCE AND RISK OF DISEASES AND INCREASING PENETRATION OF SMART PHONE AND TABLET USERS 41
3.1.3 TECHNOLOGICAL ADVANCEMENT IN HEALTHCARE IT 42
3.2 RESTRAINTS 43
3.2.1 ELECTRONICS AND TELECOMMUNICATION ISSUES 43
3.2.2 HIGH CAPITAL EXPENDITURE AND MAINTENANCE REQUIREMENT 43
3.3 OPPORTUNITIES 44
3.3.1 AFFORDABLE AND MANAGEABLE DEVICES 44
3.4 CHALLENGES 45
3.4.1 PRIVACY AND SECURITY CHALLENGES IN DIGITAL HEALTHCARE 45
3.4.2 FAILURE IN THE TRANSMISSION OF DATA 45
4 EXECUTIVE SUMMARY 47
5 PREMIUM INSIGHTS 51
6 GLOBAL DIGITAL HEALTH MONITORING DEVICES MARKET , BY PRODUCT 54
6.1 OVERVIEW 55
6.2 DEVICES 57
6.2.1 GLUCOSE MONITORING DEVICES 58
6.2.2 VITAL SIGNS MONITORING DEVICES 58
6.2.3 SLEEP MONITORING DEVICES 58
6.2.4 FETAL MONITORING & OBSTETRIC DEVICES 58
6.2.5 NEUROMONITORING DEVICES 58
6.3 SOFTWARE 58
6.3.1 CHRONIC DISEASE APPS 59
6.3.2 PERSONAL HEALTH APPS 59
6.3.3 HEALTHCARE APPS 59
6.3.4 OTHERS 59
6.4 SERVICES 60
6.4.1 REMOTE MONITORING 61
6.4.2 CONSULTANCY SERVICES 61
6.4.3 OTHERS 61
7 GLOBAL DIGITAL HEALTH MONITORING DEVICES MARKET, BY TYPE 62
7.1 OVERVIEW 63
7.2 WIRELESS HEALTH 64
7.3 MHEALTH 65
7.4 TELEHEALTH 65
7.5 EHR/EMR 66
7.6 OTHERS 66
8 GLOBAL DIGITAL HEALTH MONITORING DEVICES MARKET, BY END USER 67
8.1 OVERVIEW 68
8.2 HOSPITAL 69
8.3 HOMECARE SETTINGS 70
8.4 CLINICS 70
8.5 AMBULATORY SURGICAL CENTERS 71
8.6 OTHERS 71
9 GLOBAL DIGITAL HEALTH MONITORING DEVICES MARKET, BY GEOGRAPHY 72
9.1 OVERVIEW 73
9.2 NORTH AMERICA 78
9.2.1 U.S. 84
9.2.2 CANADA 87
9.2.3 MEXICO 90
9.3 EUROPE 93
9.3.1 GERMANY 100
9.3.2 U.K. 103
9.3.3 FRANCE 106
9.3.4 ITALY 109
9.3.5 SPAIN 112
9.3.6 SWITZERLAND 115
9.3.7 NETHERLANDS 118
9.3.8 RUSSIA 121
9.3.9 BELGIUM 124
9.3.10 TURKEY 127
9.3.11 REST OF EUROPE 130
9.4 ASIA PACIFIC 131
9.4.1 CHINA 138
9.4.2 JAPAN 141
9.4.3 INDIA 144
9.4.4 AUSTRALIA 147
9.4.5 SOUTH KOREA 150
9.4.6 SINGAPORE 153
9.4.7 MALAYSIA 156
9.4.8 INDONESIA 159
9.4.9 THAILAND 162
9.4.10 PHILLIPINES 165
9.4.11 REST OF ASIA PACIFIC 168
9.5 SOUTH AMERICA 169
9.5.1 BRAZIL 175
9.5.2 REST OF SOUTH AMERICA 178
9.6 MIDDLE EAST AND AFRICA 179
9.6.1 SOUTH AFRICA 185
9.6.2 REST OF MIDDLE EAST AND AFRICA 188
10 GLOBAL DIGITAL HEALTH MONITORING DEVICES MARKET, COMPANY LANDSCAPE 189
10.1 COMPANY SHARE ANALYSIS; GLOBAL 189
10.2 COMPANY SHARE ANALYSIS; NORTH AMERICA 190
10.3 COMPANY SHARE ANALYSIS; EUROPE 191
10.4 COMPANY SHARE ANALYSIS; ASIA PACIFIC 192
?
11 COMPANY PROFILE 193
11.1 KONINKLIJKE PHILIPS N.V. 193
11.1.1 COMPANY SNAPSHOT 193
11.1.2 REVENUE ANALYSIS 194
11.1.3 COMPANY SHARE ANALYSIS 194
11.1.4 PRODUCT PORTFOLIO 195
11.1.5 RECENT DEVELOPMENTS 196
11.2 OMRON CORPORATION 197
11.2.1 COMPANY SNAPSHOT 197
11.2.2 REVENUE ANALYSIS 197
11.2.3 COMPANY SHARE ANALYSIS 198
11.2.4 PRODUCT PORTFOLIO 198
11.2.5 RECENT DEVELOPMENTS 199
11.3 BIOTELEMETRY, INC. 200
11.3.1 COMPANY SNAPSHOT 200
11.3.2 REVENUE ANALYSIS 200
11.3.3 COMPANY SHARE ANALYSIS 201
11.3.4 PRODUCT PORTFOLIO 201
11.3.5 RECENT DEVELOPMENTS 202
11.4 IHEALTH LABS INC. 203
11.4.1 COMPANY OVERVIEW 203
11.4.2 GEOGRAPHICAL PRESENCE 203
11.4.3 PRODUCT PORTFOLIO 204
11.4.4 RECENT DEVELOPMENTS 204
11.5 ABBOTT 205
11.5.1 COMPANYSNAPSHOT 205
11.5.2 REVENUE ANALYSIS 205
11.5.3 PRODUCT PORTFOLIO 206
11.5.4 RECENT DEVELOPMENTS 207
11.6 AGFA-GEVAERT GROUP 208
11.6.1 COMPANY SNAPSHOT 208
11.6.2 REVENUE ANALYSIS 208
11.6.3 PRODUCT PORTFOLIO 209
11.6.4 RECENT DEVELOPMENTS 209
11.7 ALLSCRIPTS 210
11.7.1 COMPANY SNAPSHOT 210
11.7.2 REVENUE ANALYSIS 210
11.7.3 PRODUCT PORTFOLIO 211
11.7.4 RECENT DEVELOPMENT 211
?
11.8 BIOTRONIK 212
11.8.1 COMPANY SNAPSHOT 212
11.8.2 GEOGRAPHICAL PRESENCE 212
11.8.3 PRODUCT PORTFOLIO 213
11.8.4 RECENT DEVELOPMENTS 213
11.9 BOSTON SCIENTIFIC CORPORATION 214
11.9.1 COMPANY SNAPSHOT 214
11.9.2 REVENUE ANALYSIS 215
11.9.3 PRODUCT PORTFOLIO 215
11.9.4 RECENT DEVELOPMENT 215
11.10 CERNER CORPORATION 216
11.10.1 COMPANY SNAPSHOT 216
11.10.2 REVENUE ANALYSIS 216
11.10.3 PRODUCT PORTFOLIO 217
11.10.4 RECENT DEVELOPMENT 217
11.11 CISCO SYSTEMS, INC. 218
11.11.1 COMPANY SNAPSHOT 218
11.11.2 REVENUE ANALYSIS 218
11.11.3 PRODUCT PORTFOLIO 219
11.11.4 RECENT DEVELOPMENT 219
11.12 EPIC SYSTEMS CORPORATION 220
11.12.1 COMPANY SNAPSHOT 220
11.12.2 GEOGRAPHICAL PRESENCE 220
11.12.3 PRODUCT PORTFOLIO 221
11.12.4 RECENT DEVELOPMENT 221
11.13 HONEYWELL INTERNATIONAL INC. 222
11.13.1 COMPANY SNAPSHOT 222
11.13.2 REVENUE ANALYSIS 222
11.13.3 PRODUCT PORTFOLIO 223
11.13.4 RECENT DEVELOPMENTS 223
11.14 GENERAL ELECTRIC COMPANY 224
11.14.1 COMPANY SNAPSHOT 224
11.14.2 REVENUE ANALYSIS 224
11.14.3 PRODUCT PORTFOLIO 225
11.14.4 RECENT DEVELOPMENT 225
11.15 IBM CORPORATION 226
11.15.1 COMPANY SNAPSHOT 226
11.15.2 REVENUE ANALYSIS 226
11.15.3 PRODUCT PORTFOLIO 227
11.15.4 RECENT DEVELOPMENTS 227
11.16 MCKESSON CORPORATION 228
11.16.1 COMPANYSNAPSHOT 228
11.16.2 REVENUE ANALYSIS 228
11.16.3 PRODUCT PORTFOLIO 229
11.16.4 RECENT DEVELOPMENT 229
11.17 MEDTRONIC 230
11.17.1 COMPANY SNAPSHOT 230
11.17.2 REVENUE ANALYSIS 230
11.17.3 PRODUCT PORTFOLIO 231
11.17.4 RECENT DEVELOPMENTS 231
11.18 QUALCOMM TECHNOLOGIES, INC. 232
11.18.1 COMPANY SNAPSHOT 232
11.18.2 REVENUE ANALYSIS 232
11.18.3 PRODUCT PORTFOLIO 233
11.18.4 RECENT DEVELOPMENTS 233
11.19 SIEMENS HEALTHINEERS AG 234
11.19.1 COMPANY SNAPSHOT 234
11.19.2 REVENUE ANALYSIS 234
11.19.3 PRODUCT PORTFOLIO 235
11.19.4 RECENT DEVELOPMENT 235
12 QUESTIONNAIRE 236
13 RELATED REPORTS 237